Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Drug Concentrations: Measurements

Drug Concentrations: Measurements

Drug concentration is the quantity of a drug present in a biological sample. Measuring drug amounts in biological samples allows the clinician to understand how a drug is absorbed, distributed, metabolized, and excreted. Samples can be obtained through invasive or non-invasive methods. Invasive techniques involve surgical or parenteral interventions to gather blood, cerebrospinal fluid, or tissue biopsy. Conversely, non-invasive approaches provide samples like urine, feces, and saliva.
Plasma —...

Drug Toxicity: Dose-Dependent Reactions

Drug Toxicity: Dose-Dependent Reactions

Drug toxicities can be stratified into pharmacological, pathological, or genotoxic based on their mechanisms. The incidence and severity of these toxicities generally increase with the drug's concentration in the body and exposure time.Pharmacological toxicity is evident when the therapeutic effects of drugs overshoot into adverse reactions in a predictable, dose-dependent manner. Central nervous system (CNS) depression from barbiturates is a classic example, with effects escalating from...

Time Course of Drug Effect

Time Course of Drug Effect

The progression of a drug's impact can be analyzed by examining both the concentration-time course and the effect-time course. The concentration-time course is determined by the drug's half-life and is influenced by factors such as its pharmacokinetics, including absorption, distribution, metabolism, and elimination. The effect of the drug is often related to its concentration in the plasma and is calculated using the maximum drug effect and the plasma concentration that generates 50 percent of...

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...

Drug Concentration Versus Time Correlation

Drug Concentration Versus Time Correlation

The plasma drug concentration-time curve is a crucial tool in pharmacokinetics, representing the drug's concentration in plasma at different time intervals post-administration. This curve illustrates the drug's journey from absorption into the systemic circulation, distribution to body tissues, and eventual elimination through excretion or biotransformation.
Two pivotal parameters are the minimum effective concentration (MEC) and the minimum toxic concentration (MTC). The MEC is the lowest drug...

Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance

Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance

The elimination half-life and drug clearance of drugs following nonlinear kinetics can vary with dosage. The Michaelis-Menten parameters and drug concentration influence these factors. As the dose increases, the elimination half-life tends to lengthen, resulting in a reduction in clearance and a disproportionately larger area under the curve. The total clearance can be derived from the Michaelis-Menten equation for drugs following a one-compartment model.
A study on guinea pigs examined the...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Announcing Video Abstracts.

The American journal of forensic medicine and pathology·2025

Same author

Desalkylgidazepam.

The American journal of forensic medicine and pathology·2024

Same author

Definite SUDEP population in Bexar County, Texas: A 36-year data registry.

Epilepsy & behavior : E&B·2021

Same author

Testing an Age-old Adage: Can Autopsy Findings be of Assistance in Differentiating Opioid Versus Cardiac Deaths?

Journal of forensic sciences·2019

Same author

A 25-Year Review of Pediatric Suicides: Distinguishing Features and Risk Factors.

The American journal of forensic medicine and pathology·2019

Same author

Organ Weight Reference Ranges for Ages 0 to 12 Years.

The American journal of forensic medicine and pathology·2019

Search research articles

Related Experiment Video

Updated: Jun 3, 2026

Optimized Griess Reaction for UV-Vis and Naked-eye Determination of Anti-malarial Primaquine

Optimized Griess Reaction for UV-Vis and Naked-eye Determination of Anti-malarial Primaquine

Published on: October 11, 2019

Postmortem hydroxychloroquine concentrations in nontoxic cases.

D Kimberley Molina¹

¹Bexar County Medical Examiner's Office, 7337 Louis Pasteur Drive, San Antonio, TX 78229, USA. kmolina@bexar.org

The American Journal of Forensic Medicine and Pathology

|April 6, 2011

Summary

This summary is machine-generated.

Postmortem blood hydroxychloroquine (HCQ) concentrations in non-toxic cases can overlap with lethal levels. Autopsy and investigative data are crucial for determining cause of death, not just HCQ levels.

More Related Videos

Biochemical Measurement of Neonatal Hypoxia

Biochemical Measurement of Neonatal Hypoxia

Published on: August 24, 2011

Quantification of Neurovascular Protection Following Repetitive Hypoxic Preconditioning and Transient Middle Cerebral Artery Occlusion in Mice

Quantification of Neurovascular Protection Following Repetitive Hypoxic Preconditioning and Transient Middle Cerebral Artery Occlusion in Mice

Published on: May 4, 2015

Related Experiment Videos

Last Updated: Jun 3, 2026

Optimized Griess Reaction for UV-Vis and Naked-eye Determination of Anti-malarial Primaquine

Optimized Griess Reaction for UV-Vis and Naked-eye Determination of Anti-malarial Primaquine

Published on: October 11, 2019

Biochemical Measurement of Neonatal Hypoxia

Biochemical Measurement of Neonatal Hypoxia

Published on: August 24, 2011

Quantification of Neurovascular Protection Following Repetitive Hypoxic Preconditioning and Transient Middle Cerebral Artery Occlusion in Mice

Quantification of Neurovascular Protection Following Repetitive Hypoxic Preconditioning and Transient Middle Cerebral Artery Occlusion in Mice

Published on: May 4, 2015

Area of Science:

Forensic Toxicology
Pharmacology
Clinical Chemistry

Background:

Hydroxychloroquine (HCQ) is a 4-aminoquinoline with therapeutic uses in malaria and autoimmune diseases.
HCQ has a long half-life and high distribution volume, influencing its postmortem concentrations.
Established toxic and lethal blood concentrations for HCQ exist, but non-toxic postmortem ranges are less defined.

Purpose of the Study:

To establish the range of non-toxic postmortem blood hydroxychloroquine concentrations.
To compare these non-toxic postmortem levels with previously reported toxic and lethal concentrations.
To emphasize the importance of comprehensive data in postmortem interpretation.

Main Methods:

Analysis of postmortem blood samples from individuals known to be taking hydroxychloroquine.
Exclusion of cases with any evidence of toxicity.
Comparison of measured concentrations with literature values for therapeutic, toxic, and lethal ranges.

Main Results:

Non-toxic postmortem hydroxychloroquine concentrations were found to range from 0.3 to 39 mg/L.
This observed range significantly overlaps with previously reported toxic (3-26 mg/L) and lethal (20-104 mg/L) concentrations.
The findings indicate that elevated postmortem HCQ levels alone do not confirm toxicity or lethality.

Conclusions:

Postmortem hydroxychloroquine concentrations must be interpreted cautiously.
Investigative findings and autopsy data are essential for accurate cause of death determination.
Certification of death should not rely solely on blood hydroxychloroquine levels.